欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
LCL161_1005342-46-0_产品详情
1005342-46-0
  • names:

    LCL161

  • CAS号:

    1005342-46-0

    MDL Number:
  • MF(分子式): C26H33FN4O3S MW(分子量): 500.63
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
LCL161
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
YZM001699-10mg 10mg 99.17% ¥ 2008.80 ¥ 2008.80 2-3天
- +
¥ 0.00
YZM001699-5mg 5mg 99.17% ¥ 1329.90 ¥ 1329.90 2-3天
- +
¥ 0.00
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名
英文别名
CAS号 1005342-46-0
Inchi
InchiKey
分子式 Formula C26H33FN4O3S
分子量 Molecular Weight 500.63
溶解度Solubility 生物体外In Vitro:DMSO溶解度100 mg/mL(199.75 mM;Need ultrasonic)
性状
储藏条件 Storage conditions 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月
LCL161(CAS:1005342-46-0)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
产品说明 LCL161为IAP的抑制剂,抑制 HEK293 细胞中XIAP和 MDA-MB-231细胞中cIAP1的IC50分别为 35 和 0.4 nM
IntroductionLCL161 is aIAPinhibitor which inhibitsXIAPin HEK293 cell andcIAP1in MDAB31 cell withIC50s of 35 and 0.4 nM, respectively.
Application1
Application2
Application3
LCL161为IAP的抑制剂,抑制 HEK293 细胞中XIAP和 MDA-MB-231细胞中cIAP1的IC50分别为 35 和 0.4 nM。LCL161 is aIAPinhibitor which inhibitsXIAPin HEK293 cell andcIAP1in MDA-MB-231 cell withIC50s of 35 and 0.4 nM, respectively.
警示图
危险性
危险性警示
安全声明
安全防护
备注
【1】.Maria Ahn, et al. Potent, Dual cIAP1/XIAP Antagonists Induce Apoptosis in a Melanoma Stem Cell Population.
【2】.Chen KF, et al. Inhibition of Bcl-2 improves effect of LCL161, a SMAC mimetic, in hepatocellular carcinoma cells. Biochem Pharmacol. 2012 Aug 1;84(3):268-77.
【3】.Dhuria S, et al. Time-dependent inhibition and induction of human cytochrome P4503A4/5 by an oral IAP antagonist, LCL161, in vitro and in vivo in healthy subjects. J Clin Pharmacol. 2013 Jun;53(6):642-53.
【4】.Infante JR, et al. Phase I dose-escalation study of LCL161, an oral inhibitor of apoptosis proteins inhibitor, in patients with advanced solid tumors. J Clin Oncol. 2014 Oct 1;32(28):3103-10.
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents